Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver from Toronto with news the company has signed a deal with the distribution company Active Therapeutics. This agreement allows Innocan to move into the U.K. and Ireland.
Bincovich also told Proactive about the work they will be doing with Hebrew University and also about a new board member who comes with a very big resume.
CSE:INNO
Market: CSE
Market Cap: $14.39 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of InnoCan Pharma named herein, including the promotion by the Company of InnoCan Pharma in any Content on the Site, the Company receives from...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
InnoCan Pharma looking at their CBD by injection technology as a game changer
InnoCan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive in Toronto to talk about the CBDcompnay and some of their interesting technology including the development of CBD by Injection. Bincovich also told Proactive about their topical vertical that will focus on pain...
on 11/04/2019
2 min read
Prev article
2 min read
